NivolumabInterstitial lung disease: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1712卷 / 1期

关键词：

D O I：

10.1007/s40278-018-49687-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：398 / 398

相关论文

共 50 条

[31] Ipilimumab/nivolumabInterstitial pneumonitis and hypophysitis: case report
Reactions Weekly, 2021, 1868 (1) : 226 - 226
[32] NivolumabInterstitial pneumonia, and exacerbation of plaque psoriasis: case report
Reactions Weekly, 2016, 1587 (1) : 209 - 209
[33] NivolumabInterstitial pneumonia and off label use: case report
Reactions Weekly, 2020, 1826 (1) : 254 - 254
[34] PanitumumabInterstitial lung disease: case report
Reactions Weekly, 2013, 1451 (1) : 39 - 39
[35] Hydatid disease of the lung - With a case report
Evans, RG
LANCET, 1934, 1 : 1281 - 1283
[36] PembrolizumabInterstitial lung disease: case report
Reactions Weekly, 2020, 1817 (1) : 270 - 270
[37] PanitumumabInterstitial lung disease: case report
Reactions Weekly, 2020, 1787 (1) : 406 - 406
[38] PembrolizumabInterstitial lung disease: case report
Reactions Weekly, 2019, 1778 (1) : 370 - 370
[39] IpilimumabGranulomatous lung disease: case report
Reactions Weekly, 2017, 1681 (1) : 195 - 195
[40] CrizotinibInterstitial lung disease: case report
Reactions Weekly, 2014, 1516 (1) : 68 - 68

← 1 2 3 4 5 →